BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2002
View Archived Issues
Viventia options anticancer hybridomas from M.D. Cancer Center
Read More
VaxGen awarded government contract for anthrax vaccine
Read More
Clinical section of Vitrase NDA submitted
Read More
DAC:GLP-1 phase I results delayed
Read More
Cortex and Servier expand Ampakine research collaboration
Read More
IL-21 added to ZymoGenetics development pipeline
Read More
Safety and pharmacokinetics of LY-451395 in healthy volunteers
Read More
Glutamate mglu5-selective antagonist may potentiate activity of conventional AEDs
Read More
Pimecrolimus a highlight of this year's EADV congress
Read More
Antiepileptic drugs in bipolar disorder
Read More
Olanzapine/fluoxetine combination in major depression
Read More
Two series of PPARalpha and/or PPARgamma agonists identified at Dr. Reddy's
Read More
Inhibitors of TGF-beta signaling pathway described in GSK patent
Read More
Pharmacia evaluating inhibitors of viral DNA polymerase
Read More
Novel GlyT-2 inhibitors and their use in psychosis, pain, epilepsy, etc.
Read More
Potential antidiabetic thiazolidinones prepared and tested at Merck
Read More
Merck patent covers novel alpha1A-adrenoceptor antagonists and their use in BPH
Read More
Novel beta3-adrenoceptor agonists under study at BMS
Read More
VRC-3375 used as a lead to develop more potent antibacterial PDF inhibitors
Read More
Neuropharmacological profile of SLV-313, a dual D2 antagonist/5-HT1A agonist
Read More
Korean research demonstrates stimulation of hair growth following culture with epigallocatechin
Read More
Timing of single doses of FK-506 important for limb allograft success
Read More
Thrombin-related peptide accelerates fracture healing in first human trial
Read More
Karo Bio and Bristol-Myers Squibb extend obesity collaboration
Read More
Initiation of phase II Triapine trial in head and neck cancer
Read More
Enrollment completed in phase II Theratope trial for metastatic colorectal cancer
Read More
Fuzeon, the first HIV fusion inhibitor, will receive a priority review at the FDA
Read More